CPS Technologies (CPSH) CEO receives new staged option grants

Rhea-AI Filing Summary

CPS Technologies CEO Brian T. Mackey reported compensation-related grants of stock options. On May 21, 2026, he received four grants of 2,500 Common Stock options each, covering 2,500 underlying shares per grant at an exercise price of $4.67 per share.

The options become exercisable in stages on May 21 of 2027, 2028, 2029, and 2030, and each grant expires on May 21, 2036. These are awards from the company rather than open-market share purchases.

Insider Trade Summary

4 transactions reported

Mixed 4 txns

Insider Mackey Brian T

Role CEO

Type	Security	Shares	Price	Value
Grant/Award	Common Stock Option	2,500	$4.67	$12K
Grant/Award	Common Stock Option	2,500	$4.67	$12K
Grant/Award	Common Stock Option	2,500	$4.67	$12K
Grant/Award	Common Stock Option	2,500	$4.67	$12K

Holdings After Transaction: Common Stock Option — 242,500 shares (Direct, null)

Footnotes (1)

Key Figures

Option grant size per tranche: 2,500 options Total underlying shares across grants: 10,000 shares Exercise price: $4.67 per share +4 more

7 metrics

Option grant size per tranche 2,500 options Each Common Stock Option grant on May 21, 2026

Total underlying shares across grants 10,000 shares Four grants of 2,500 underlying Common Stock shares each

Exercise price $4.67 per share Conversion or exercise price for each option grant

First exercisability date May 21, 2027 One tranche of options becomes exercisable on this date

Latest exercisability date May 21, 2030 Final tranche of options becomes exercisable on this date

Expiration date May 21, 2036 Expiration for all reported option grants

Derivative transactions count 4 transactions All coded as A (grant, award, or other acquisition)

Key Terms

Common Stock Option, Grant, award, or other acquisition, derivative, exercise price

4 terms

Common Stock Option financial

"security_title: "Common Stock Option""

Grant, award, or other acquisition financial

"transaction_code_description: "Grant, award, or other acquisition""

derivative financial

"transaction_type: "derivative""

A derivative is a financial contract whose value depends on the price or performance of another asset or measure — for example a stock, index, interest rate, commodity, or currency. Investors use derivatives like insurance or leveraged bets to hedge risk, speculate, or gain exposure without owning the underlying asset; they can protect portfolios but also amplify losses and introduce counterparty and market risk.

exercise price financial

"conversion_or_exercise_price: "4.6700""

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Mackey Brian T

(Last) (First) (Middle)

792 WEST STREET

C108

(Street)

MANSFIELD MASSACHUSETTS 02048

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CPS TECHNOLOGIES CORP/DE/ [ CPSH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/21/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Common Stock Option	$4.67	05/21/2026		A		2,500		05/21/2027	05/21/2036	Common Stock	2,500	$4.67	242,500	D
Common Stock Option	$4.67	05/21/2026		A		2,500		05/21/2028	05/21/2036	Common Stock	2,500	$4.67	245,000	D
Common Stock Option	$4.67	05/21/2026		A		2,500		05/21/2029	05/21/2036	Common Stock	2,500	$4.67	247,500	D
Common Stock Option	$4.67	05/21/2026		A		2,500		05/21/2030	05/21/2036	Common Stock	2,500	$4.67	250,000	D

Explanation of Responses:

	Brian T Mackey	05/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did CPSH CEO Brian T. Mackey report in his latest Form 4?

Brian T. Mackey reported receiving four grants of Common Stock options as compensation. Each grant relates to 2,500 underlying CPS Technologies shares, awarded on May 21, 2026, with future exercisability and a common expiration date in 2036.

How many CPS Technologies (CPSH) options were granted to CEO Brian Mackey?

Brian Mackey received four option grants, each covering 2,500 underlying Common Stock shares. In total, the Form 4 shows option awards tied to 10,000 CPS Technologies shares, structured as separate tranches with different future exercise dates but the same expiration in 2036.

At what exercise price were the new CPSH stock options granted to the CEO?

All reported option grants to CEO Brian Mackey have an exercise price of $4.67 per share. This means he can purchase CPS Technologies Common Stock at $4.67 when each tranche becomes exercisable on its respective future exercise date before expiration.

When do Brian Mackey’s CPSH option grants become exercisable and when do they expire?

The option tranches become exercisable on May 21 of 2027, 2028, 2029, and 2030. Each grant shares the same expiration date of May 21, 2036, giving a multi-year window after vesting for potential exercise of these CPS Technologies options.

Are Brian Mackey’s new CPS Technologies (CPSH) options open-market purchases?

No, the Form 4 shows code “A” transactions described as “Grant, award, or other acquisition.” These are compensation-related stock option awards from CPS Technologies, not open-market share purchases or sales initiated by CEO Brian Mackey.